NCT06872489 2025-07-23Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsSecond Life TherapeuticsAvailable
NCT05179824 2025-05-06Tempus Priority Study: A Pan-tumor Observational StudyTempus AIActive not recruiting1,000 enrolled
NCT02045368 2019-08-22Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RIGF Oncology, LLCPhase 1 Completed92 enrolled
NCT00120939 2009-04-03Study of Motexafin Gadolinium and Docetaxel for Advanced CancerPharmacyclics LLC.Phase 1 Completed25 enrolled